The triggering receptor expressed on myeloid cells-2 (TREM2) plays a central role in regulating myeloid cell maturation and function in the setting of numerous human pathologies, including neurodegenerative diseases, metabolic diseases, and cancers [1]. This evidence concerns the gene TREM2 and metabolic disease.